OTCMKTS:ORINY Orion OYJ Q2 2025 Earnings Results & Report $57.89 0.00 (0.00%) As of 11/12/2026 02:59 PM Eastern Orion OYJ reported Q2 2025 earnings on July 18, 2025. The company reported EPS of $0.33, while revenue was $472.57 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2025Report DateJuly 18, 2025TimeBefore Market Opens Orion OYJ EPS ResultsActual EPS$0.33Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AOrion OYJ Revenue ResultsActual Revenue$472.57 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Orion OYJ Q2 2025 Earnings FAQ Did Orion OYJ beat earnings estimates for Q2 2025? Orion OYJ (OTCMKTS:ORINY) reported earnings of $0.33 per share for Q2 2025. The report was announced on Friday, July 18, 2025. What was Orion OYJ's revenue for Q2 2025? Orion OYJ reported revenue of $472.57 million for Q2 2025. Orion OYJ Earnings HeadlinesOrion OyjJuly 12, 2026 | fool.comOrion Oyj Record 2025 Results Put Board Changes And Valuation In FocusFebruary 15, 2026 | finance.yahoo.comTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they did. Before a single vote was counted, the IMF flagged markets as increasingly exposed to a sharp correction, Ray Dalio called conditions a classic bubble, and Peter Schiff said a downturn could hit regardless of the outcome.November 13 at 1:00 AM | USA Capital Gold (Ad)Does Orion Oyj (HLSE:ORNBV) Dividend Hike Clarify Its Oncology-Pivot Capital Allocation Strategy?February 14, 2026 | finance.yahoo.comOrion Oyj (ORINY) Q4 2025 Earnings Call Highlights: Record Growth and Strategic DevelopmentsFebruary 12, 2026 | finance.yahoo.comAssessing Orion Oyj (HLSE:ORNBV) Valuation After A Strong 1 Year Shareholder ReturnFebruary 7, 2026 | finance.yahoo.comSee More Orion OYJ Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Orion OYJ? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Orion OYJ and other key companies, straight to your email. Email Address About Orion OYJOrion OYJ (OTCMKTS:ORINY) is a Finnish pharmaceutical company that develops, manufactures and markets medicines for human and veterinary use. Its portfolio includes prescription and over-the-counter medicines, as well as active pharmaceutical ingredients supplied to other pharmaceutical companies. Founded in 1917 and headquartered in Espoo, Finland, Orion has a long history in the pharmaceutical industry. The company focuses on areas including oncology, neurology and respiratory diseases, and develops some products in collaboration with international pharmaceutical partners. Orion serves customers in Finland and other European markets, while partnerships and product sales extend its reach to markets around the world. Its operations also include research and development, manufacturing and the commercialization of medicines.View Orion OYJ ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco's Record $30 Dividend Shows Just How Strong Its Cash Machine IsThese 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went ShoppingGolden Dome’s $185 Billion Question: Who Actually Gets Paid?3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record Growth Upcoming Earnings Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
